It is to be emphasized that for the current study and for all reported studies, the divergence between murine PSMA and human PSMA is a limitation in murine preclinical studies and could lead to different signal ratios of the tumor to kidneys and other PSMA-expressing organs in humans [33]. The gene discussed is FOLH1; the disease is neoplasm.